{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:45:22Z","timestamp":1792759522607,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00066-019-01460-7","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T16:28:38Z","timestamp":1554913718000},"page":"677-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison","Konsolidierende mediastinale Bestrahlung maligner Lymphome mittels aktivem Rasterscanning mit Protonenstrahlen: Klinische Ergebnisse und dosimetrischer Vergleich"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8402-6694","authenticated-orcid":false,"given":"Laila","family":"K\u00f6nig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Bougatf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"H\u00f6rner-Rieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naved","family":"Chaudhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kl\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias Felix","family":"Haefner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Haberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Herfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,10]]},"reference":[{"issue":"1","key":"1460_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijrobp.2005.06.004","volume":"64","author":"T Girinsky","year":"2006","unstructured":"Girinsky T et al (2006) Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin\u2019s disease, and is there a\u00a0role for beam orientation optimization and dose constraints assigned to virtual volumes? Int J Radiat Oncol Biol Phys 64(1):218\u2013226","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1460_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijrobp.2004.08.048","volume":"62","author":"KA Goodman","year":"2005","unstructured":"Goodman KA et al (2005) Intensity-modulated radiotherapy for lymphoma involving the mediastinum. Int J Radiat Oncol Biol Phys 62(1):198\u2013206","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"1460_CR3","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.2013.51.4505","volume":"32","author":"G Held","year":"2014","unstructured":"Held G et al (2014) Role of radiotherapy to bulky disease in elderly patients with aggressive B\u2011cell lymphoma. J\u00a0Clin Oncol 32(11):1112\u20131118","journal-title":"J Clin Oncol"},{"issue":"13","key":"1460_CR4","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2015.64.9418","volume":"34","author":"AK Ng","year":"2016","unstructured":"Ng AK et al (2016) Re-examining the role of radiation therapy for diffuse large B\u2011cell lymphoma in the modern era. J\u00a0Clin Oncol 34(13):1443\u20131447","journal-title":"J Clin Oncol"},{"issue":"11","key":"1460_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S1470-2045(11)70235-2","volume":"12","author":"M Pfreundschuh","year":"2011","unstructured":"Pfreundschuh M et al (2011) CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6\u2011year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol 12(11):1013\u20131022","journal-title":"Lancet Oncol"},{"issue":"7","key":"1460_CR6","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1000067","volume":"363","author":"A Engert","year":"2010","unstructured":"Engert A et al (2010) Reduced treatment intensity in patients with early-stage Hodgkin\u2019s lymphoma. N\u00a0Engl J Med 363(7):640\u2013652","journal-title":"N Engl J Med"},{"issue":"9","key":"1460_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1200\/JCO.2011.38.5807","volume":"30","author":"B Tresckow von","year":"2012","unstructured":"von Tresckow B et al (2012) Dose-intensification in early unfavorable Hodgkin\u2019s lymphoma: final analysis of the German Hodgkin Study Group HD14 trial. J\u00a0Clin Oncol 30(9):907\u2013913","journal-title":"J Clin Oncol"},{"issue":"9828","key":"1460_CR8","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(11)61940-5","volume":"379","author":"A Engert","year":"2012","unstructured":"Engert A et al (2012) Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin\u2019s lymphoma (HD15 trial): a\u00a0randomised, open-label, phase 3 non-inferiority trial. Lancet 379(9828):1791\u20131799","journal-title":"Lancet"},{"issue":"1","key":"1460_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","volume":"89","author":"T Illidge","year":"2014","unstructured":"Illidge T et al (2014) Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 89(1):49\u201358","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1460_CR10","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","volume":"89","author":"L Specht","year":"2014","unstructured":"Specht L et\u00a0al (2014) Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys 89(4):854\u2013862","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"1460_CR11","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1088\/0031-9155\/45\/11\/313","volume":"45","author":"M Kramer","year":"2000","unstructured":"Kramer M et al (2000) Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. Phys Med Biol 45(11):3299\u20133317","journal-title":"Phys Med Biol"},{"issue":"Suppl 2","key":"1460_CR12","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/S0167-8140(04)80021-5","volume":"73","author":"M Kramer","year":"2004","unstructured":"Kramer M et\u00a0al (2004) Treatment planning for scanned ion beams. Radiother Oncol 73(Suppl 2):S80\u2013S85","journal-title":"Radiother Oncol"},{"issue":"11","key":"1460_CR13","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1088\/0031-9155\/45\/11\/314","volume":"45","author":"M Kramer","year":"2000","unstructured":"Kramer M, Scholz M (2000) Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose. Phys Med Biol 45(11):3319\u20133330","journal-title":"Phys Med Biol"},{"key":"1460_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1748-717X-9-94","volume":"9","author":"KR Voong","year":"2014","unstructured":"Voong KR et al (2014) Dosimetric advantages of a\u00a0\u201cbutterfly\u201d technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin\u2019s lymphoma. Radiat Oncol 9:94","journal-title":"Radiat Oncol"},{"issue":"1","key":"1460_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B et\u00a0al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21(1):109\u2013122","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1460_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/0168-9002(93)91335-K","volume":"330","author":"T Haberer","year":"1993","unstructured":"Haberer T et\u00a0al (1993) Magnetic scanning system for heavy ion therapy. Nucl Instrum Methods Phys Res A 330(1):296\u2013305","journal-title":"Nucl. Instrum. Methods. Phys. Res. A."},{"issue":"4","key":"1460_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/0971-6203.103606","volume":"37","author":"T Kataria","year":"2012","unstructured":"Kataria T et\u00a0al (2012) Homogeneity index: an objective tool for assessment of conformal radiation treatments. J\u00a0Med Phys 37(4):207\u2013213","journal-title":"J Med Phys"},{"issue":"5","key":"1460_CR18","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/0360-3016(93)90548-A","volume":"27","author":"E Shaw","year":"1993","unstructured":"Shaw E et\u00a0al (1993) Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys 27(5):1231\u20131239","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1460_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cmpb.2014.02.002","volume":"114","author":"KA Kessel","year":"2014","unstructured":"Kessel KA et al (2014) Five-year experience with setup and implementation of an integrated database system for clinical documentation and research. Comput Methods Programs Biomed 114(2):206\u2013217","journal-title":"Comput Methods Programs Biomed"},{"key":"1460_CR20","volume-title":"Towards secondary use of heterogeneous radio-oncological data for retrospective clinical trials: service-oriented connection of a\u00a0central research database with image analysis tools","author":"N Bougatf","year":"2015","unstructured":"Bougatf N, Bendl R, Debus J (2015) Towards secondary use of heterogeneous radio-oncological data for retrospective clinical trials: service-oriented connection of a\u00a0central research database with image analysis tools"},{"issue":"5","key":"1460_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD et\u00a0al (2007) Revised response criteria for malignant lymphoma. J\u00a0Clin Oncol 25(5):579\u2013586","journal-title":"J Clin Oncol"},{"issue":"1","key":"1460_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ijrobp.2011.06.1959","volume":"83","author":"BS Hoppe","year":"2012","unstructured":"Hoppe BS et al (2012) Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a\u00a0Phase II study. Int J Radiat Oncol Biol Phys 83(1):260\u2013267","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1460_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijrobp.2011.12.034","volume":"84","author":"BS Hoppe","year":"2012","unstructured":"Hoppe BS et\u00a0al (2012) Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 84(2):449\u2013455","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9\u201310","key":"1460_CR24","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1080\/0284186X.2016.1191665","volume":"55","author":"C Zeng","year":"2016","unstructured":"Zeng C et\u00a0al (2016) Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment. Acta Oncol 55(9\u201310):1132\u20131138","journal-title":"Acta Oncol"},{"issue":"15","key":"1460_CR25","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC et\u00a0al (2006) Chronic health conditions in adult survivors of childhood cancer. N\u00a0Engl J Med 355(15):1572\u20131582","journal-title":"N Engl J Med"},{"issue":"32","key":"1460_CR26","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1200\/JCO.2012.48.0467","volume":"31","author":"G Held","year":"2013","unstructured":"Held G et al (2013) Impact of rituximab and radiotherapy on outcome of patients with aggressive B\u2011cell lymphoma and skeletal involvement. J\u00a0Clin Oncol 31(32):4115\u20134122","journal-title":"J Clin Oncol"},{"issue":"32","key":"1460_CR27","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1200\/JCO.2010.33.9549","volume":"29","author":"P Borchmann","year":"2011","unstructured":"Borchmann P et al (2011) Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin\u2019s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group. J\u00a0Clin Oncol 29(32):4234\u20134242","journal-title":"J Clin Oncol"},{"issue":"2","key":"1460_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.radonc.2008.05.012","volume":"88","author":"T Girinsky","year":"2008","unstructured":"Girinsky T et al (2008) The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines. Radiother Oncol 88(2):202\u2013210","journal-title":"Radiother Oncol"},{"issue":"12","key":"1460_CR29","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s00066-017-1186-x","volume":"193","author":"E Holzhauser","year":"2017","unstructured":"Holzhauser E et al (2017) Patterns of failure of diffuse large Bcell lymphoma patients after involved-site radiotherapy. Strahlenther Onkol 193(12):1014\u20131023","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"1460_CR30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/pbc.24861","volume":"61","author":"MV Maraldo","year":"2014","unstructured":"Maraldo MV et\u00a0al (2014) The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma. Pediatr Blood Cancer 61(4):717\u2013722","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1460_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijrobp.2006.01.027","volume":"65","author":"EJ Hall","year":"2006","unstructured":"Hall EJ (2006) Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65(1):1\u20137","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1460_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","volume":"34","author":"FA Nimwegen van","year":"2016","unstructured":"van Nimwegen FA et al (2016) Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin Lymphoma. J\u00a0Clin Oncol 34(3):235\u2013243","journal-title":"J Clin Oncol"},{"issue":"17","key":"1460_CR33","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","volume":"128","author":"SE Lipshultz","year":"2013","unstructured":"Lipshultz SE et al (2013) Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a\u00a0scientific statement from the American Heart Association. Circulation 128(17):1927\u20131995","journal-title":"Circulation"},{"issue":"8","key":"1460_CR34","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1200\/JCO.2008.20.2267","volume":"28","author":"M Tukenova","year":"2010","unstructured":"Tukenova M et al (2010) Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J\u00a0Clin Oncol 28(8):1308\u20131315","journal-title":"J Clin Oncol"},{"issue":"1","key":"1460_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1182\/asheducation-2016.1.323","volume":"2016","author":"FE Leeuwen van","year":"2016","unstructured":"van Leeuwen FE, Ng AK (2016) Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. Hematology Am Soc Hematol Educ Program 2016(1):323\u2013330","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"16","key":"1460_CR36","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","volume":"129","author":"FA Nimwegen van","year":"2017","unstructured":"van Nimwegen FA et\u00a0al (2017) Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood 129(16):2257\u20132265. \n                    https:\/\/doi.org\/10.1182\/blood-2016-09-740332","journal-title":"Blood"},{"issue":"2","key":"1460_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7326\/M15-0424","volume":"164","author":"DA Mulrooney","year":"2016","unstructured":"Mulrooney DA et al (2016) Cardiac outcomes in adult survivors of childhood cancer exposed to Cardiotoxic therapy: a cross-sectional study. Ann Intern Med 164(2):93\u2013101","journal-title":"Ann Intern Med"},{"issue":"26","key":"1460_CR38","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","volume":"373","author":"M Schaapveld","year":"2015","unstructured":"Schaapveld M et\u00a0al (2015) Second cancer risk up to 40 years after treatment for Hodgkin\u2019s Lymphoma. N\u00a0Engl J Med 373(26):2499\u20132511","journal-title":"N Engl J Med"},{"issue":"21","key":"1460_CR39","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","volume":"32","author":"CS Moskowitz","year":"2014","unstructured":"Moskowitz CS et\u00a0al (2014) Breast cancer after chest radiation therapy for childhood cancer. J\u00a0Clin Oncol 32(21):2217\u20132223","journal-title":"J Clin Oncol"},{"issue":"26","key":"1460_CR40","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1200\/JCO.2008.19.9174","volume":"27","author":"ML Bruin De","year":"2009","unstructured":"De Bruin ML et\u00a0al (2009) Breast cancer risk in female survivors of Hodgkin\u2019s lymphoma: lower risk after smaller radiation volumes. J\u00a0Clin Oncol 27(26):4239\u20134246","journal-title":"J Clin Oncol"},{"issue":"18","key":"1460_CR41","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1088\/0031-9155\/50\/18\/007","volume":"50","author":"HY Jiang","year":"2005","unstructured":"Jiang HY et al (2005) Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment. Phys Med Biol 50(18):4337\u20134353","journal-title":"Phys Med Biol"},{"issue":"4","key":"1460_CR42","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1016\/j.ijrobp.2011.01.061","volume":"81","author":"DL Andolino","year":"2011","unstructured":"Andolino DL et al (2011) Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of Hodgkin\u2019s lymphoma in female pediatric patients. Int J Radiat Oncol Biol Phys 81(4):e667\u201371","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1460_CR43","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0360-3016(01)02826-7","volume":"53","author":"U Schneider","year":"2002","unstructured":"Schneider U et\u00a0al (2002) Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys 53(1):244\u2013251","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1460_CR44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1667\/0033-7587(2000)154[0382:CRAOSC]2.0.CO;2","volume":"154","author":"U Schneider","year":"2000","unstructured":"Schneider U, Lomax A, Lombriser N (2000) Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin\u2019s disease with photon and proton radiation. Radiat Res 154(4):382\u2013388","journal-title":"Radiat Res"},{"issue":"1","key":"1460_CR45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijrobp.2013.04.030","volume":"87","author":"CS Chung","year":"2013","unstructured":"Chung CS et\u00a0al (2013) Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys 87(1):46\u201352","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"1460_CR46","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1088\/0031-9155\/59\/10\/2457","volume":"59","author":"RA Halg","year":"2014","unstructured":"Halg RA et\u00a0al (2014) Measurements of the neutron dose equivalent for various radiation qualities, treatment machines and delivery techniques in radiation therapy. Phys Med Biol 59(10):2457\u20132468","journal-title":"Phys Med Biol"},{"key":"1460_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fonc.2015.00235","volume":"5","author":"U Schneider","year":"2015","unstructured":"Schneider U, Halg R (2015) The impact of neutrons in clinical proton therapy. Front Oncol 5:235","journal-title":"Front Oncol"},{"issue":"5","key":"1460_CR48","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.ijrobp.2006.08.014","volume":"66","author":"B Gottschalk","year":"2006","unstructured":"Gottschalk B (2006) Neutron dose in scattered and scanned proton beams: in regard to Eric J. Hall (Int J Radiat Oncol Biol Phys 2006;65:1\u20137). Int J Radiat Oncol Biol Phys 66(5):1594 (author reply 1595)","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1460_CR49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijrobp.2014.01.043","volume":"89","author":"D Richter","year":"2014","unstructured":"Richter D et al (2014) Four-dimensional patient dose reconstruction for scanned ion beam therapy of moving liver tumors. Int J Radiat Oncol Biol Phys 89(1):175\u2013181","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01460-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-019-01460-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01460-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T23:21:27Z","timestamp":1586388087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-019-01460-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,10]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1007\/s00066-019-01460-7","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,10]]},"assertion":[{"value":"5 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"L.\u00a0K\u00f6nig, N.\u00a0Bougatf, J.\u00a0H\u00f6rner-Rieber, N.\u00a0Chaudhri, T.\u00a0Mielke, S.\u00a0Kl\u00fcter, M.F.\u00a0Haefner, S.\u00a0Rieken, T.\u00a0Haberer, J.\u00a0Debus and K.\u00a0Herfarth declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical approval was obtained from the local Ethics Committee of Heidelberg University (S-201\/2017).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}